Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: Report of a case

被引:3
|
作者
Turner, Kathleen [1 ]
Sandri, Giovanni Battista Levi [1 ]
Boucher, Eveline [2 ,4 ]
Henno, Sebastien [3 ]
Le Prise, Elisabeth [2 ]
Meunier, Bernard [1 ]
Boudjema, Karim [1 ,4 ]
Sulpice, Laurent [1 ,4 ]
机构
[1] Univ Rennes 1, CHU Rennes, Serv Chirurg Hepatobiliaire & Digest, F-35033 Rennes, France
[2] Univ Rennes 1, Ctr Reg Lutte Canc, F-35042 Rennes, France
[3] Univ Rennes 1, CHU Rennes, Serv Anat & Cytol Pathol, F-35033 Rennes, France
[4] Univ Rennes 1, INSERM, UMR991, Liver Metab & Canc, F-35033 Rennes, France
关键词
OUTCOMES; CHEMOTHERAPY; GEMCITABINE;
D O I
10.1016/j.clinre.2014.08.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E29 / E31
页数:3
相关论文
共 50 条
  • [21] Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer
    Sui, Kenta
    Okabayashi, Takehiro
    Shima, Yasuo
    Morita, Sojiro
    Iwata, Jun
    Sumiyoshi, Tatsuaki
    Saisaka, Yuichi
    Hata, Yasuhiro
    Noda, Yoshihiro
    Matsumoto, Manabu
    Nishioka, Akihito
    Iiyama, Tastuo
    Shimada, Yasuhiro
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1075):
  • [22] Clinical effects of chemoradiotherapy toward optimal treatment of locally advanced unresectable pancreatic cancer
    Okabayashi, Takehiro
    Shima, Yasuo
    Morita, Sojiro
    Iwata, Jun
    Sumiyoshi, Tatsuaki
    Kozuki, Akihito
    Tokumaru, Teppei
    Saisaka, Yuichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 259 - 259
  • [23] Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis
    Wang, Zi-Meng
    Ma, Hong-Bin
    Meng, Yan
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [24] Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis
    Zi-Meng Wang
    Hong-Bin Ma
    Yan Meng
    BMC Gastroenterology, 23
  • [25] A R0 Resection Case of Initially Unresectable Metastatic Pancreatic Cancer Downstaged by FOLFIRINOX Therapy
    Sasaki, Takashi
    Isayama, Hiroyuki
    Aoki, Taku
    Tanaka, Mariko
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Morikawa, Teppei
    Fukayama, Masashi
    Kokudo, Norihiro
    Koike, Kazuhiko
    PANCREAS, 2014, 43 (06) : 972 - 974
  • [26] Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
    Ferrone, Cristina R.
    Marchegiani, Giovanni
    Hong, Theodore S.
    Ryan, David P.
    Deshpande, Vikram
    McDonnell, Erin I.
    Sabbatino, Francesco
    Santos, Daniela Dias
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Faris, Jason E.
    Goyal, Lipika
    Kwak, Eunice L.
    Murphy, Janet E.
    Ting, David T.
    Wo, Jennifer Y.
    Zhu, Andrew X.
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2015, 261 (01) : 12 - 17
  • [27] Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
    Wu, Lili
    Zhou, Yuhong
    Fan, Yue
    Rao, Shengxiang
    Ji, Yuan
    Sun, Jing
    Li, Tingting
    Du, Shisuo
    Guo, Xi
    Zeng, Zhaochong
    Lou, Wenhui
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [28] Modified-FOLFIRINOX-losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: A phase II study
    Alhanafy, A. M.
    Abd El Bary, N.
    Hegazy, O.
    Abd El Ghany, A.
    Soliman, S. H.
    Ahmed, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S902 - S902
  • [30] Chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: a retrospective cohort study
    Maruki, Y.
    Ueno, H.
    Sasaki, M.
    Sakamoto, Y.
    Kondo, S.
    Morizane, C.
    Ito, Y.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2016, 27 : 35 - 35